Clinical Trials Directory

Trials / Completed

CompletedNCT04140422

Eye Drops for Early Morning-Associated Corneal Swelling of the Cornea

Efficacy of Hyperosmolar Eye Drops in Diurnal Corneal Edema in Fuchs Endothelial Dystrophy: a Double Blind Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
68 (actual)
Sponsor
University Eye Hospital, Freiburg · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the efficacy of hyperosmolar eye drops on early morning edema of the cornea in patients with Fuchs' endothelial corneal dystrophy (FECD). Each participant will receive hyperosmolar eye drops in one eye and lubricating eye drops in the fellow eye.

Detailed description

Hyperosmolar eye drops are lubricating eye drops with 5% of sodium chloride. Hyperosmolar eye drops are thought to temporarily deswell the cornea. During morning hours, patients with Fuchs' endothelial corneal dystrophy (FECD) typically report poor vision and disturbing glare because of corneal edema. To improve vision in advanced stages of the disease, corneal endothelial transplantation has become the treatment of choice. Many patients with Fuchs' endothelial corneal dystrophy (FECD) use hyperosmolar eye drops before transplantation. At present, it is unclear, how much hyperosmolar eye drops help reducing corneal edema in Fuchs' endothelial corneal dystrophy (FECD). Based on our previous work that determined the amount of additional corneal edema in the morning in patients with Fuchs' endothelial corneal dystrophy (FECD), the investigators will assess if hyperosmolar eye drops speed up the deswelling process.

Conditions

Interventions

TypeNameDescription
OTHERHyperosmolar eye dropsApplication of one preservative-free hyperosmolar eye drop, when waking up and one eye drop 30 min later to one eye by the investigators
OTHERPlaceboApplication of one preservative-free lubricating eye drop, when waking up and one eye drop 30 min later to the fellow eye by the investigators

Timeline

Start date
2019-10-24
Primary completion
2020-06-25
Completion
2020-06-25
First posted
2019-10-25
Last updated
2020-07-15

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT04140422. Inclusion in this directory is not an endorsement.